New way for states to cover pricey gene therapies will start with sickle cell disease
Nada Hassanein | Stateline.org (TNS) The U.S. Food and Drug Administration late last year approved two breakthrough gene therapies for sickle cell disease patients. Now a new federal program seeks to make these life-changing treatments available to patients with low … Continued